| Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions JR Gamble, J Drew, L Trezise, A Underwood, M Parsons, L Kasminkas, ... Circulation research 87 (7), 603-607, 2000 | 696 | 2000 |
| From sewer to saviour—targeting the lymphatic system to promote drug exposure and activity NL Trevaskis, LM Kaminskas, CJH Porter Nature reviews Drug discovery 14 (11), 781-803, 2015 | 608 | 2015 |
| Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties LM Kaminskas, BJ Boyd, CJH Porter Nanomedicine 6 (6), 1063-1084, 2011 | 218 | 2011 |
| Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy LM Kaminskas, VM McLeod, GM Ryan, BD Kelly, JM Haynes, ... Journal of Controlled Release 183, 18-26, 2014 | 213 | 2014 |
| A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems LM Kaminskas, VM McLeod, BD Kelly, G Sberna, BJ Boyd, M Williamson, ... Nanomedicine: Nanotechnology, Biology and Medicine 8 (1), 103-111, 2012 | 202 | 2012 |
| The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly l-Lysine Dendrimers LM Kaminskas, BJ Boyd, P Karellas, GY Krippner, R Lessene, B Kelly, ... Molecular pharmaceutics 5 (3), 449-463, 2008 | 202 | 2008 |
| Cationic Poly-l-lysine Dendrimers: Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats BJ Boyd, LM Kaminskas, P Karellas, G Krippner, R Lessene, CJH Porter Molecular pharmaceutics 3 (5), 614-627, 2006 | 180 | 2006 |
| Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-l-lysine Dendrimers LM Kaminskas, BD Kelly, VM McLeod, BJ Boyd, GY Krippner, ED Williams, ... Molecular pharmaceutics 6 (4), 1190-1204, 2009 | 177 | 2009 |
| New developments in dry powder pulmonary vaccine delivery T Sou, EN Meeusen, M de Veer, DAV Morton, LM Kaminskas, ... Trends in biotechnology 29 (4), 191-198, 2011 | 169 | 2011 |
| The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules T Sou, LM Kaminskas, TH Nguyen, R Carlberg, MP McIntosh, DAV Morton European Journal of Pharmaceutics and Biopharmaceutics 83 (2), 234-243, 2013 | 160 | 2013 |
| PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats LM Kaminskas, J Kota, VM McLeod, BD Kelly, P Karellas, CJH Porter Journal of Controlled Release 140 (2), 108-116, 2009 | 160 | 2009 |
| Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation LM Kaminskas, VM McLeod, CJH Porter, BJ Boyd Molecular pharmaceutics 9 (3), 355-373, 2012 | 159 | 2012 |
| Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker LM Kaminskas, BD Kelly, VM McLeod, G Sberna, DJ Owen, BJ Boyd, ... Journal of controlled release 152 (2), 241-248, 2011 | 150 | 2011 |
| Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products PC Burcham, LM Kaminskas, FR Fontaine, DR Petersen, SM Pyke Toxicology 181, 229-236, 2002 | 145 | 2002 |
| Targeting the lymphatics using dendritic polymers (dendrimers) LM Kaminskas, CJH Porter Advanced drug delivery reviews 63 (10-11), 890-900, 2011 | 136 | 2011 |
| Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent GM Ryan, LM Kaminskas, BD Kelly, DJ Owen, MP McIntosh, CJH Porter Molecular Pharmaceutics 10 (8), 2986-2995, 2013 | 128 | 2013 |
| Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers GM Ryan, LM Kaminskas, CJH Porter Journal of Controlled Release 193, 241-256, 2014 | 125 | 2014 |
| Influence of size and shape on the biodistribution of nanoparticles prepared by polymerization-induced self-assembly S Kaga, NP Truong, L Esser, D Senyschyn, A Sanyal, R Sanyal, JF Quinn, ... Biomacromolecules 18 (12), 3963-3970, 2017 | 107 | 2017 |
| Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice LM Kaminskas, SM Pyke, PC Burcham Journal of Pharmacology and Experimental Therapeutics 310 (3), 1003-1010, 2004 | 106 | 2004 |
| Polymer-drug conjugates as inhalable drug delivery systems: A review N Marasini, S Haque, LM Kaminskas Current Opinion in Colloid & Interface Science 31, 18-29, 2017 | 91 | 2017 |
Chris PorterDirector, Monash Institute of Pharmaceutical Sciences, Monash University在 monash.edu 的电子邮件经过验证
